April 1, 2011
PGXL Laboratories partners with AutoGenomics to expand Molecular Testing in Pharmacogenetics

December 21, 2010
AutoGenomics launches the INFINITI^® FMF Panel

October 26, 2010
AutoGenomics Receives FDA Clearance for its INFINITI^® CYP2C19 Assay

Tuesday, February 23, 2010
AutoGenomics announces the launch of a novel test for B-RAF mutations

Wednesday, February 17, 2010
AutoGenomics Receives ISO Certification

Wednesday, January 6, 2010
AIBioTech partners with AutoGenomics to expand Molecular testing

Friday, July 25, 2008
AutoGenomics, Inc. Files Registration Statement for Initial Public Offering

Monday, July 7, 2008
AutoGenomics INFINITI Analyzer Receives Artistic Design Award

Wednesday, June 18, 2008
AutoGenomics receives a key European patent for HPV detection

Monday, March 31, 2008
AutoGenomics appoints Dr. Laurence M. Demers and Eric S. Kentor to its Board of Directors

Wednesday, January 23, 2008
AutoGenomics Receives FDA Clearance for its INFINITI™ Warfarin Assay

Friday, August 17, 2007
Harvard Partners successfully validates 2C9-VKORC1 panel

Friday, June 1, 2007
AutoGenomics addresses TB crisis with a genetic Drug Resistance test

Wednesday, May 2, 2007
AutoGenomics Receives FDA Clearance for Its Infiniti Analyzer

Wednesday, March 28, 2007
AutoGenomics Closes Series C Private Placement Offering


Monday, February 12, 2007
AutoGenomics Receives 510(k) Clearance for INFINITI™ Assay for Factor II & Factor V Leiden


Monday, December 11, 2006
AutoGenomics Files Infiniti Warfarin-Metabolism Assay With FDA for 510(k) Clearance